| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.017 | 0.9 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.0024 | 0.9 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |